Rbf Capital, LLC X Biotech Inc. Transaction History
Rbf Capital, LLC
- $1.87 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding XBIT
# of Institutions
54Shares Held
4.7MCall Options Held
200Put Options Held
12.8K-
Black Rock Inc. New York, NY1.13MShares$3.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA455KShares$1.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny264KShares$816,9180.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$769,6370.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $94.4M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...